
Oral Presentation at APASL Annual Assembly 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Succeed in Useful Remedy of Continual Hepatitis B
HANGZHOU and SHAOXING, China, Feb. 16, 2023 /PRNewswire/ —
Stay Safe and Healthy
HANGZHOU and SHAOXING, China, Feb. 16, 2023 /PRNewswire/ —